Dr. Scott Andrew Powell, MD

Dr. Powell practices at ENT and Allergy Associates of Florida in Boca Raton, Florida.

Dr. Powell's NPI, 1447266820, was assigned on July 31, 2006. Dr. Powell graduated from USF Health Morsani College of Medicine in 2002. Dr. Powell holds Florida license ME91115.

Dr. Powell's primary practice is ENT and Allergy Associates of Florida, at 900 NW 13th St, Boca Raton, FL 33486 in Palm Beach County. The practice phone is (561) 338-3267.

Dr. Powell's primary practice is ENT and Allergy Associates of Florida in Boca Raton, Florida. Dr. Powell is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is ENT & Allergy Associates of Florida. Dmand AI also links Dr. Powell to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Powell practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Powell's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Powell is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Powell is licensed in Florida.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Powell treats.

CMS data shows 2,725 Medicare services from Dr. Powell across 28 procedure codes in 2024, for 398 Medicare patients. Medicare paid $170,132 for them. Every service was in an office.

CMS counts 398 Medicare patients who saw Dr. Powell in 2024. The largest group is 65 to 74, with 185 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Powell's median patient age at 60, with 56% women.

In 2024, Dr. Powell wrote 1,054 Medicare Part D claims for 382 patients. 93% of them were for generic drugs. CMS names the drug for 982 of them, across 17 drugs with 11 or more claims each, at $141,375 in total drug cost. In 2023, CMS named 1,092 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Powell for performance year 2024, reported individually. Dr. Powell accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Powell. The most frequent topics are Diagnosis, Differential. Dr. Powell has published most often in MLO Med Lab Obs. Dr. Powell's most frequent co-authors are Richard F. Lockey, MD and Chau Tuan Nguyen, MD.

Dmand AI links Dr. Powell to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Rhinitis and Nose Diseases. Open Payments lists research payments to Dr. Powell that name 3 trials.

CMS Open Payments shows 375 general payments to Dr. Powell from 45 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 37% of the total. Optinose US, Inc. paid the most, $16,552. It also lists 11 research payments totaling $100,614 from 2023 to 2025, naming 3 clinical trials.

Dmand AI lists 2 awards for Dr. Powell, most recently CMS Stage 1 EHR in 2013.

Dr. Powell graduated from USF Health Morsani College of Medicine in 2002. Dr. Powell is a member of NHS.

Dr. Powell is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.